
Unlocking the Missing Puzzle Piece in Cancer Real-World Data

Value Proposition for Life Science Companies
- Characterize burden of illness, patient functional status, symptom impact on real-world time-on-treatment (rwToT)
- Evaluate comparative Patient Experience across evidence-based options
- Identify sub-populations benefiting from treatment
- Understand patient adherence and patient populations
- Provide Patient Experience Data for new drug applications
- Create synthetic control arms
- Use regulatory grade data to support FDA submissions for label expansion
- Identify hospitalization & discontinuation trends by treatment
- Understand comparative overall cost of care across evidence-based options
- Collaborate with payors/providers on care management strategies to improve value
Building the Largest Real-World Cancer Patient Experience Database
Carevive OPT-IN® – The Oncology Pragmatic Trial Investigator Network
Funded by a growing list of life science companies, Carevive OPT-IN® is a novel and unique real-world patient experience dataset consisting of EHR-derived clinical data and longitudinal patient-reported outcomes (PRO). Together, this combination presents the most comprehensive picture of real-world symptoms of disease and treatment in cancer.
Life science companies can license these data to:
- Support drug development, commercial, and market access efforts with novel evidence and insights including how and when therapies are being used in the real-world setting, differences between trial results and real-world data and longitudinal patient experience
- Conduct bespoke research in collaboration with Carevive OPT-IN® sites and their patients
- Become Carevive design-partners in other cancer types
Tumor registries to be initiated in 2020-2022
Myeloma
LIVE
Chronic Lymphocytic Leukemia
Renal Cell Carcinoma
Breast Cancer
LIVE
DLBCL
Follicular Lymphoma
Urothelial
Lung Cancer
LIVE
Ovarian Cancer
LIVE
Hepatocellular Carcinoma
Prostate Cancer
AML
LIVE
Stomach Cancer
Colorectal Carcinoma
Pancreatic Cancer
Head and Neck
0
Total US 2019 Analytic Cases
0
Carevive OPT-IN® Network Analytic Cases
0
%
Share of Total Cancer Market
OPT-imizing Patient Experience Data
